Teva Pharmaceuticals
TEVA
TEVA
539 hedge funds and large institutions have $16.2B invested in Teva Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 177 increasing their positions, 160 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 506 → 539 (+33)
0.74% less ownership
Funds ownership: 66.24% → 65.51% (-0.74%)
20% less call options, than puts
Call options by funds: $614M | Put options by funds: $765M
Holders
539
Holding in Top 10
16
Calls
$614M
Puts
$765M
Top Buyers
| 1 | +$162M | |
| 2 | +$135M | |
| 3 | +$100M | |
| 4 |
Citigroup
New York
|
+$97M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$90.7M |
Top Sellers
| 1 | -$393M | |
| 2 | -$246M | |
| 3 | -$206M | |
| 4 |
NC
Northern Cross
Boston,
Massachusetts
|
-$48.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.5M |